Category: Home

Metabolic syndrome hypertension

Metabolic syndrome hypertension

Mettabolic Heart, Lung, and Blood Institute. The State of Victoria and Carbohydrate digestion process Department of Health shall sybdrome bear any Coenzyme Q and thyroid function for reliance by any user on the materials hypertensiin on this website. The primary end-point was the composite of death from cardiovascular causes, non-fatal myocardial infarction, non-fatal stroke, hospitalisation for angina, resuscitation after sudden cardiac arrest and coronary revascularisation. Also try to avoid spending prolonged periods of time sitting down, by standing up or going for a one-to-two minute walk. Yes No. Continue Find out more.

Video

Inflammatory Tales in Cardiovascular Medicine (Joseph A. Hill, MD)

Metabolic syndrome hypertension -

In people with insulin resistance, cells don't respond normally to insulin and glucose can't enter the cells as easily. As a result, your blood sugar levels rise even as your body churns out more and more insulin to try to lower your blood sugar. A lifelong commitment to a healthy lifestyle may prevent the conditions that cause metabolic syndrome.

A healthy lifestyle includes:. On this page. When to see a doctor. Risk factors. Apple and pear body shapes.

A Book: The Essential Diabetes Book. A Book: The Mayo Clinic Diet Bundle. Request an appointment. From Mayo Clinic to your inbox. Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health.

Click here for an email preview. To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information.

If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices.

You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail. Metabolic syndrome is closely linked to overweight or obesity and inactivity.

The following factors increase your chances of having metabolic syndrome: Age. Your risk of metabolic syndrome increases with age.

In the United States, Hispanics — especially Hispanic women — appear to be at the greatest risk of developing metabolic syndrome. The reasons for this are not entirely clear. Carrying too much weight, especially in your abdomen, increases your risk of metabolic syndrome.

You're more likely to have metabolic syndrome if you had diabetes during pregnancy gestational diabetes or if you have a family history of type 2 diabetes. Other diseases. Your risk of metabolic syndrome is higher if you've ever had nonalcoholic fatty liver disease, polycystic ovary syndrome or sleep apnea.

Having metabolic syndrome can increase your risk of developing: Type 2 diabetes. If you don't make lifestyle changes to control your excess weight, you may develop insulin resistance, which can cause your blood sugar levels to rise.

Eventually, insulin resistance can lead to type 2 diabetes. Heart and blood vessel disease. High cholesterol and high blood pressure can contribute to the buildup of plaques in your arteries.

These plaques can narrow and harden your arteries, which can lead to a heart attack or stroke. A healthy lifestyle includes: Getting at least 30 minutes of physical activity most days Eating plenty of vegetables, fruits, lean protein and whole grains Limiting saturated fat and salt in your diet Maintaining a healthy weight Not smoking.

By Mayo Clinic Staff. May 06, Show References. Ferri FF. Metabolic syndrome. In: Ferri's Clinical Advisor Elsevier; Accessed March 1, National Heart, Lung, and Blood Institute. Metabolic syndrome syndrome X; insulin resistance syndrome. Merck Manual Professional Version. March 2, About metabolic syndrome.

American Heart Association. Meigs JB. Metabolic syndrome insulin resistance syndrome or syndrome X. Prevention and treatment of metabolic syndrome. Lear SA, et al. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H: Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity.

European Group for the Study of Insulin Resistance EGIR. Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.

Arch Intern Med. Reaven GM: Role of insulin resistance in human disease syndrome X : an expanded definition. Annu Rev Med.

Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Katagiri H, Yamada T, Oka Y: Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.

Circ Res. Miller JH, Bogdonoff MD: Antidiuresis associated with administration of insulin. J Appl Physiol. Nizet A, Lefebvre P, Crabbe J: Control by insulin of sodium potassium and water excretion by the isolated dog kidney.

Pflugers Arch. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. Article CAS PubMed PubMed Central Google Scholar. Sechi LA: Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity.

Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, D'Elia L, Russo O, Versiero M, Farinaro E, Cappuccio FP: Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. Rocchini AP: Obesity hypertension, salt sensitivity and insulin resistance.

Nutr Metab Cardiovasc Dis. CAS PubMed Google Scholar. Sarafidis PA, Bakris GL: Insulin and endothelin: an interplay contributing to hypertension development?. J Clin Endocrinol Metab. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G: Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives.

Julius S, Krause L, Schork NJ, Mejia AD, Jones KA, van de Ven C, Johnson EH, Sekkarie MA, Kjeldsen SE, Petrin J: Hyperkinetic borderline hypertension in Tecumseh, Michigan.

Julius S, Jamerson K: Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Mancia G: Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

Wolk R, Shamsuzzaman AS, Somers VK: Obesity, sleep apnea, and hypertension. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP: Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J.

Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G: Sympathetic activation in obese normotensive subjects.

Grassi G: Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. Egan BM: Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep. J Hum Hypertens. Correia ML, Haynes WG: Obesity-related hypertension: is there a role for selective leptin resistance?.

Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA: The sympathetic nervous system and the metabolic syndrome. Barnard RJ, Roberts CK, Varon SM, Berger JJ: Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome.

Sarafidis PA, Bakris GL: The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?. Am J Nephrol. Meigs JB, Larson MG, Fox CS, Keaney JF, Vasan RS, Benjamin EJ: Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study.

Kim JA, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG: Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women.

Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G: The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int J Biochem Cell Biol. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM: Co-expression of renin-angiotensin system genes in human adipose tissue.

Goodfriend TL, Egan BM, Kelley DE: Aldosterone in obesity. Endocr Res. Egan BM, Stepniakowski K, Goodfriend TL: Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.

Am J Hypertens. Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M: Plasma aldosterone is independently associated with the metabolic syndrome.

Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, Kotchen TA: Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Sowers JR: Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol.

Ridker PM, Wilson PW, Grundy SM: Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?.

Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-reactive protein and the risk of developing hypertension. Grundy SM: Inflammation, hypertension, and the metabolic syndrome. Kahaleh MB, Fan PS: Effect of cytokines on the production of endothelin by endothelial cells.

Clin Exp Rheumatol. Brasier AR, Li J, Wimbish KA: Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P: Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians.

Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG: Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.

Dorffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR: Preactivated peripheral blood monocytes in patients with essential hypertension. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W: Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP: Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines.

Am J Physiol. Besedovsky HO, del Rey A: Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin a pilot study in fibromyalgia.

Arthritis Rheum. Takano M, Itoh N, Yayama K, Yamano M, Ohtani R, Okamoto H: Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen. Biochem Pharmacol. Parish JM, Adam T, Facchiano L: Relationship of metabolic syndrome and obstructive sleep apnea.

J Clin Sleep Med. Article PubMed PubMed Central Google Scholar. Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T: Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Lam JC, Ip MS: An update on obstructive sleep apnea and the metabolic syndrome.

Curr Opin Pulm Med. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK: Sympathetic activity in obese subjects with and without obstructive sleep apnea. Download references. Department of Internal Medicine, The Jikei University School of Medicine, Chiba, Japan.

Department of Laboratory Medicine, The Jikei University School of Medicine, Chiba, Japan. You can also search for this author in PubMed Google Scholar.

Correspondence to Hidekatsu Yanai. This article is published under license to BioMed Central Ltd. Reprints and permissions. Yanai, H. et al. The underlying mechanisms for development of hypertension in the metabolic syndrome. Nutr J 7 , 10 Download citation. Received : 16 December Accepted : 17 April Published : 17 April Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search.

Download PDF. Download ePub. Abstract High blood pressure is an important constituent of the metabolic syndrome. Introduction The metabolic syndrome is characterized by the simultaneous occurrence of metabolic abnormalities including obesity, glucose intolerance, dyslipidemia, and hypertension, that result in a marked increase in cardiovascular morbidity and mortality [ 1 — 3 ].

The underlying mechanisms for development of hypertension in the metabolic syndrome Proposed mechanisms for development of hypertension in the metabolic syndrome were shown in Figure 1.

Figure 1. Full size image. Conclusion Visceral obesity, insulin resistance, oxidative stress, endothelial dysfunction, activated renin-angiotensin system, increased inflammatory mediators, and obstructive sleep apnea have been proposed to be possible factors to develop hypertension in the metabolic syndrome.

References Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III.

Article Google Scholar World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complication.

Article PubMed Google Scholar Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A: Metabolic syndrome and target organ damage in untreated essential hypertensives.

Article CAS PubMed Google Scholar Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E: Prognostic value of the metabolic syndrome in essential hypertension. Article PubMed Google Scholar Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H: Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity.

Article CAS PubMed Google Scholar Kaplan NM: The deadly quartet. Article CAS PubMed Google Scholar Reaven GM: Role of insulin resistance in human disease syndrome X : an expanded definition. Article CAS PubMed Google Scholar Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

Article CAS PubMed Google Scholar Katagiri H, Yamada T, Oka Y: Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Article CAS PubMed Google Scholar Miller JH, Bogdonoff MD: Antidiuresis associated with administration of insulin.

Article CAS PubMed Google Scholar Nizet A, Lefebvre P, Crabbe J: Control by insulin of sodium potassium and water excretion by the isolated dog kidney. Article CAS PubMed Google Scholar DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.

Article CAS PubMed PubMed Central Google Scholar Sechi LA: Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. Article CAS PubMed Google Scholar Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, D'Elia L, Russo O, Versiero M, Farinaro E, Cappuccio FP: Abnormalities of renal sodium handling in the metabolic syndrome.

Article CAS PubMed Google Scholar Rocchini AP: Obesity hypertension, salt sensitivity and insulin resistance. CAS PubMed Google Scholar Sarafidis PA, Bakris GL: Insulin and endothelin: an interplay contributing to hypertension development?.

Article CAS PubMed Google Scholar Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G: Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. Article CAS PubMed Google Scholar Julius S, Krause L, Schork NJ, Mejia AD, Jones KA, van de Ven C, Johnson EH, Sekkarie MA, Kjeldsen SE, Petrin J: Hyperkinetic borderline hypertension in Tecumseh, Michigan.

Article CAS PubMed Google Scholar Julius S, Jamerson K: Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question.

Article CAS PubMed Google Scholar Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Mancia G: Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

Article CAS PubMed Google Scholar Wolk R, Shamsuzzaman AS, Somers VK: Obesity, sleep apnea, and hypertension. Article CAS PubMed Google Scholar Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP: Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.

Article PubMed Google Scholar Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G: Sympathetic activation in obese normotensive subjects.

Article CAS PubMed Google Scholar Grassi G: Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. Article CAS PubMed Google Scholar Egan BM: Insulin resistance and the sympathetic nervous system.

Nutrition Journal volume Carbohydrate digestion processArticle number: 10 Cite this hypertenion. Metrics details. High blood pressure syndome an important constituent syndome the syndgome syndrome. However, the underlying mechanisms hypertensioh development Metabolic syndrome hypertension hypertension in the metabolic syndrome are very complicated and remain still obscure. Here, we will discuss how these factors influence on development of hypertension in the metabolic syndrome. The metabolic syndrome is characterized by the simultaneous occurrence of metabolic abnormalities including obesity, glucose intolerance, dyslipidemia, and hypertension, that result in a marked increase in cardiovascular morbidity and mortality [ 1 — 3 ]. Metabolic syndrome hypertension Metabolic syndrome is a syncrome of conditions hypertensiom occur together, increasing your Carbohydrate digestion process of synrome disease, stroke and Metabolic syndrome hypertension 2 diabetes. Hypertenion conditions include increased blood Metabilic, high blood Metabollc, excess body fat around the waist, and abnormal cholesterol or Beetroot juice for menstrual health levels. People who have metabolic syndrome typically have apple-shaped bodies, meaning they have larger waists and carry a lot of weight around their abdomens. It's thought that having a pear-shaped body that is, carrying more of your weight around your hips and having a narrower waist doesn't increase your risk of diabetes, heart disease and other complications of metabolic syndrome. Having just one of these conditions doesn't mean you have metabolic syndrome. But it does mean you have a greater risk of serious disease.

Author: Nezshura

1 thoughts on “Metabolic syndrome hypertension

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com